SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-004015
Filing Date
2020-03-16
Accepted
2020-03-16 16:06:44
Documents
80
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1354908
2 ex4-4.htm EX-4.4 22230
3 ex21.htm EX-21 3340
4 ex23-1.htm EX-23.1 3688
5 ex31-1.htm EX-31.1 16828
6 ex31-2.htm EX-31.2 16443
7 ex32.htm EX-32 8215
8 image_001.jpg GRAPHIC 21924
9 image_002.jpg GRAPHIC 21939
10 image_003.jpg GRAPHIC 10426
11 image_004.jpg GRAPHIC 31850
  Complete submission text file 0001493152-20-004015.txt   5198522

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE abeo-20191231.xml EX-101.INS 859412
13 XBRL SCHEMA FILE abeo-20191231.xsd EX-101.SCH 48929
14 XBRL CALCULATION FILE abeo-20191231_cal.xml EX-101.CAL 70901
15 XBRL DEFINITION FILE abeo-20191231_def.xml EX-101.DEF 198897
16 XBRL LABEL FILE abeo-20191231_lab.xml EX-101.LAB 349201
17 XBRL PRESENTATION FILE abeo-20191231_pre.xml EX-101.PRE 297951
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 20717133
SIC: 2834 Pharmaceutical Preparations